Acteoside significantly attenuated Parkinsonism symptoms by inhibiting rotenone-induced α-synuclein and caspase-3 upregulation, and microtubule-associated protein 2 downregulation in PD rats [108]. The gene discussed is CASP3; the disease is Parkinson disease.